Table 1.
Clinical characteristics of the included patients in the therapy and the control group.
| Therapy Group (n = 20) | Control Group (n = 20) | |
|---|---|---|
| Male, n | 12 (60%) | 8 (40%) |
| Gestattional age (weeks) Gestation age (weeks), range |
28.6 (±2.4) 23 + 6–31 + 4 |
28.9 (2.7) 23 + 2–31 + 6 |
| Birth weight (g) Birth weight (g), range |
1059 (±389) 340–1700 |
1201 (±404) 580–2120 |
| Died, n (age at death) | 1 (9 days) | 1 (152 days) |
| APGAR score at 10 min APGAR score at min, range |
8.7 (±0.7) 7.0–10.0 |
8.7 (±1.0) 6.0–10.0 |
| Early onset sepsis, n | 5 (25%) | 4 (20%) |
| Late onset sepsis, n | 4 (20%) | 5 (25%) |
| Bronchopulmonary dypslasia (mild), n | 1 (5%) | 2 (10%) |
| Bronchopulmonary dypslasia (severe), n | 1 (5%) | 1 (5%) |
| Intraventricular hemorrhage °I–II, n | 4 (20%) | 3 (15%) |
| Intraventricular hemorrhage °III, n | 1 (5%) | 0 |
| Necrotizing enterocolitis, n | 1 (5%) | 0 |
| Patent ductus arteriosus (total), n | 11 (55%) | 7 (35%) |
| Medical therapy, n | 10 (50%) | 7 (35%) |
| Surgery, n | 1 (5%) | 0 |
| Antibiotic treatment, days | 8.7 (10.8) | 8.4 (17.7) |
Notes. SD = standard deviation. APGAR = Appearance, Pulse, Grimace, Activity, and Respiration. Data are presented as the mean (standard deviation) if not indicated otherwise.